Cargando…
MFTZ-1 reduces constitutive and inducible HIF-1α accumulation and VEGF secretion independent of its topoisomerase II inhibition
The macrolide compound MFTZ-1 has been identified as a novel topoisomerase II (Top2) inhibitor with potent in vitro and in vivo anti-tumour activities. In this study, we further examined the effects of MFTZ-1 on hypoxia-inducible factor-1α (HIF-1α) accumulation, vascular endothelial growth factor (V...
Autores principales: | Dai, Mei, Miao, Ze-Hong, Ren, Xuan, Tong, Lin-Jiang, Yang, Na, Li, Ting, Lin, Li-Ping, Shen, Yue-Mao, Ding, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822569/ https://www.ncbi.nlm.nih.gov/pubmed/19538463 http://dx.doi.org/10.1111/j.1582-4934.2009.00822.x |
Ejemplares similares
-
Activation of Protease-Activated Receptor 2 Induces VEGF Independently of HIF-1
por: Rasmussen, Jeppe Grøndahl, et al.
Publicado: (2012) -
Vhl deletion in renal epithelia causes HIF-1α-dependent, HIF-2α-independent angiogenesis and constitutive diuresis
por: Schönenberger, Désirée, et al.
Publicado: (2016) -
The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners
por: Zhang, Yanan, et al.
Publicado: (2016) -
Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis
por: Wang, Jichang, et al.
Publicado: (2015) -
The Changes of HIF-1α and VEGF Expression After TACE in Patients With Hepatocellular Carcinoma
por: Liu, Kang, et al.
Publicado: (2016)